Pacific Biosciences of California, Inc. (PACB) CEO Mike Hunkapiller on Q4 2019 Results - Earnings Call Transcript

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2019 Earnings Conference Call February 6, 2020 4:30 PM ET

Company Participants

Trevin Rard - Investor Relations
Mike Hunkapiller - Chief Executive Officer
Susan Barnes - Chief Financial Officer
Ben Gong - Vice President of Finance & Treasurer

Conference Call Participants

Rachel Vatnsdal - Piper Sandler

Operator

Good afternoon, ladies and gentlemen. Thank you for standing by and welcome to the Pacific Biosciences of California Fourth Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call may be recorded.

I would now like to turn the conference over to Trevin Rard. Thank you. Please, go ahead.

Trevin Rard

Good afternoon and welcome to the Pacific Biosciences Fourth Quarter and Fiscal 2019 Conference Call. Earlier today, we issued a press release outlining the financial results we will be discussing in today's call, a copy of which is available on the Investors section of our website at www.pacb.com or alternatively, as furnished on the Form 8-K available on the Securities and Exchange Commission website at www.sec.gov.

With me today are Mike Hunkapiller, our Chief Executive Officer; Susan Barnes, our Chief Financial Officer; and Ben Gong, our Vice President of Finance and Treasurer.

Before we begin, I would like to remind you that on today’s call, we may be making forward-looking statements, including plans and expectations relating to our financial projections, products and other future events. You should not place undue reliance on forward-looking statements, because they are subject to assumptions, risks and uncertainties, and may differ materially from actual results. These risks and uncertainties are more fully described in our Securities and Exchange Commission filings, including our most recently filed reports on forms 8-K, 10-K and Form 10-Q.